Health, Fitness & Food

The Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024.  Adam Glanzman | Bloomberg | Getty Images Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing lower expected sales in Europe, a “competitive environment” for respiratory vaccines in the U.S. and the potential for deferred

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S.,

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Thursday reported second-quarter earnings and revenue that topped estimates and hiked its full-year guidance, as the company’s cost cuts showed progress and sales of its breakthrough Alzheimer’s drug, Leqembi, and

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.  Shelby Knowles | Bloomberg | Getty Images Eli Lilly‘s weight loss drug Zepbound showed benefits in patients with a common type of heart

The eponymous sign outside Epic headquarters in Verona, Wisconsin. Source: Yiem via Wikipedia CC It’s about to get a lot easier for patients in the U.S. to access their own medical records.  Health-care software vendor Epic Systems on Thursday announced that individuals will be able to securely release their health data to different apps they

In this article ME Follow your favorite stocksCREATE FREE ACCOUNT A sign is posted in front of the 23andMe headquarters in Sunnyvale, California, on Feb. 1, 2024. Justin Sullivan | Getty Images Anne Wojcicki, CEO of 23andMe, has submitted a proposal to take the genetic testing company private as its stock price continues to hover

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market slides : The S & P 500 gave back earlier gains and fell throughout Tuesday afternoon, led lower by the mega-cap tech stocks. Ahead of the

In this article 4523.T-JP Follow your favorite stocksCREATE FREE ACCOUNT The newly FDA approved Alzheimer’s treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on Tuesday, November 7, 2023.  Hannah Yoon | The Washington Post | Getty Images The breakthrough Alzheimer’s drug Leqembi slowed disease progression in patients over three years, demonstrating the

In this article AAPL Follow your favorite stocksCREATE FREE ACCOUNT Mark uses the Vision Pro with his BCI Courtesy of Synchron Neurotech startup Synchron on Tuesday announced it has connected its brain implant to Apple‘s Vision Pro headset. It’s now possible for patients with limited physical mobility to control the device using only their thoughts. 

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market moves: The S & P 500 was on track for small gains following a solid rally last Friday. There’s still some market rotation happening, but

We’re making four trades Monday morning. Shortly after the opening bell, we will be selling 100 shares of Danaher at roughly $274.13. Following the trade, Jim Cramer’s Charitable Trust will own 475 shares of Danaher, decreasing its weighting in the portfolio to 4% from 4.84%. In addition, we will be selling 20 shares of Salesforce at

Fruit bats seen hanging on tree branches in daylight. Bats are believed to be one of the carriers of Nipah virus, a zoonotic disease that spreads from animals to humans. Eyepix Group | Future Publishing | Getty Images Health authorities in the southern Indian state of Kerala are on high alert following the latest flare-up of the

In this article AMZN GEHC Follow your favorite stocksCREATE FREE ACCOUNT Jakub Porzycki | Nurphoto | Getty Images GE HealthCare on Thursday announced it is teaming up with Amazon Web Services to build new generative artificial intelligence models and tools that can efficiently analyze complex medical data. The health-care industry is responsible for generating nearly

In this article BMY Follow your favorite stocksCREATE FREE ACCOUNT The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Friday reported second-quarter earnings and revenue that topped expectations and raised its full-year guidance as the

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. Stocks jumped Friday as Wall Street tried to end a turbulent week on a jubilant note. The Dow Jones Industrial Average added more more than 600 points, or 1.6%. The

Kevin Sayer, CEO, Dexcom Scott Mlyn | CNBC Dexcom shares sank more than 40% on Friday and headed for their worst day ever after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance. The stock fell $45.38 to $62.47 as of early afternoon, wiping out about $18 billion in

In this article 4523.T-JP BIIB Follow your favorite stocksCREATE FREE ACCOUNT Eisai | via Reuters European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating another hurdle for the companies as they scramble to boost uptake of the therapy in the U.S.  The European Commission, the EU’s executive body, has

In this article DXCM Follow your favorite stocksCREATE FREE ACCOUNT The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Shares of Dexcom tumbled more than 35% in extended trading Thursday after the diabetes management company reported disappointing revenue for the second

In this article LLY VKTX NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Weight loss drug concept. Cr | Istock | Getty Images Shares of Viking Therapeutics jumped more than 20% on Thursday after the biotech company a day earlier announced plans to advance its experimental weight loss injection into a late-stage trial earlier than expected. 

In this article SGMO PFE Follow your favorite stocksCREATE FREE ACCOUNT Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval. The treatment for hemophilia A could become the company’s